EUVIMEDEUVIMED entdecken
Crossref

Study on Sgc8 aptamer-mediated nucleic acid nanomaterial-doxorubicin complex for tumor targeted therapy

Xuemei Hu, Jing Zhang, Qi Xiang, Guoqiao Huang, Quan Yuan, Yuzhe Wang, Zhifa Shen

European Journal of Pharmaceutics and Biopharmaceutics · 2023

DOI: 10.1016/j.ejpb.2023.02.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2023. Verfasst von Xuemei Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, Department of Cell Biology and …. Hauptthemen laut MEDLINE: Nucleic Acids, Aptamers, Nucleotide, Neoplasms, Nanostructures. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy is one of the most important treatments for malignant cancers, but most chemotherapeutic drugs are poorly targeted, highly toxic and expensive, resulting in unsatisfactory treatment results for cancer patients. Therefore, intelligent drug delivery platforms are needed to be explored urgently to enhance drug treatment and reduce toxicity on normal cells. Nucleic acid nanomaterials are a class of nanomaterials developed on the basis of the "base complementary pairing principle", which have the advantages of good programmability, high stability, good biocompatibility, and strong targeting. Herein, we present a simple Sgc8 aptamer-modified nucleic acid nanomaterial (Sgc8NM) for the targeted delivery of Doxorubicin (Dox), a widely used chemotherapy drug in clinic. Studies have shown the Sgc8NM-Dox performed a precise treatment effect on target cells and low toxicity on non-target cells, providing a new strategy for the potential application of nanocomposite drugs in targeted cancer delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nucleic AcidsAptamers, NucleotideNeoplasmsNanostructuresHumansDoxorubicinDrug Delivery SystemsCell Line, Tumor

Stichwörter der Autor:innen

DoxorubicinNucleic acid nanomaterialsSgc8 aptamerTargeted therapyTumor

Substanzen

Nucleic AcidsAptamers, NucleotideDoxorubicin

Autor:innen und Institutionen

  • Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, Department of Cell Biology and Medical Genetics, College of Laboratory Medicine and Life sciences, We…

Förderung

  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Hu, X., Zhang, J., Xiang, Q., Huang, G., Yuan, Q., Wang, Y., & Shen, Z. (2023). Study on Sgc8 aptamer-mediated nucleic acid nanomaterial-doxorubicin complex for tumor targeted therapy. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2023.02.009

Vancouver

Hu X, Zhang J, Xiang Q, Huang G, Yuan Q, Wang Y, et al. Study on Sgc8 aptamer-mediated nucleic acid nanomaterial-doxorubicin complex for tumor targeted therapy. European Journal of Pharmaceutics and Biopharmaceutics. 2023. doi:10.1016/j.ejpb.2023.02.009

BibTeX
@article{Hu2023,
  author = {Hu, Xuemei and Zhang, Jing and Xiang, Qi and Huang, Guoqiao and Yuan, Quan and Wang, Yuzhe and Shen, Zhifa},
  title = {Study on Sgc8 aptamer-mediated nucleic acid nanomaterial-doxorubicin complex for tumor targeted therapy},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2023},
  doi = {10.1016/j.ejpb.2023.02.009}
}
Kostenlos starten →